Interactions of antileukemic drugs with daunorubicin reductases: could reductases affect the clinical efficacy of daunorubicin chemoregimens?
Novotná, Eva, Morell, Anselm, Büküm, Neslihan, Hofman, Jakub, Danielisová, Petra, Wsól, VladimÃrJournal:
Archives of Toxicology
DOI:
10.1007/s00204-020-02818-y
Date:
June, 2020
File:
PDF, 908 KB
2020